Literature DB >> 8608471

Importance of complete staging in non-Hodgkin's lymphoma presenting as a cerebral mass lesion.

A J Ferreri1, M Reni, M C Zoldan, M R Terreni, E Villa.   

Abstract

BACKGROUND: The high incidence of local failure and the lack of evidence of systemic dissemination of primary central nervous system lymphoma (PCNSL) has led some authors to conclude that complete staging with extensive tests is not necessary in patients with a lymphomatous cerebral mass who present with a focal neural syndrome. Moreover, De Angelis emphasizes that there is no report in the literature of systemic lymphoma presenting as a cerebral mass lesion, whereas others conclude that an extensive systemic evaluation is unnecessary or that the staging should be limited to physical examination, routine blood studies, and a chest radiography.
METHODS: In 16 PCNSL patients observed between 1982 and 1992, we found two patients showing systemic involvement of lymphoma after staging workup with chest X-ray, total body computerized tomographic (CT) scan, cerebrospinal fluid cytology examination, and bone marrow biopsy. In one patient, a CT abdominal scan showed retroperitoneal and pelvic lymphonodal involvement, whereas in the second patient, bone marrow biopsy was positive. These systemic onsets were found no later than 2 months after the diagnosis of central nervous system involvement, which is sufficient time to conclude that these locations were present at the diagnosis of the cerebral mass.
RESULTS: In the present study, complete staging demonstrated widespread dissemination (lymph nodes or bone marrow) in two patients with initial neurologic symptoms and a cerebral mass lesion.
CONCLUSIONS: In our experience, complete staging allowed detection of systemic lymphoma in two patients initially considered to have PCNSL.

Entities:  

Mesh:

Year:  1996        PMID: 8608471     DOI: 10.1002/(sici)1097-0142(19960301)77:5<827::aid-cncr4>3.0.co;2-b

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  16 in total

1.  Systemic chemotherapy with vincristine, cyclophosphamide, doxorubicin and prednisolone following radiotherapy for primary central nervous system lymphoma: a phase II study.

Authors:  Y Shibamoto; K Sasai; N Oya; M Hiraoka
Journal:  J Neurooncol       Date:  1999-04       Impact factor: 4.130

2.  Staging identifies non-CNS malignancies in a large cohort with newly diagnosed lymphomatous brain lesions.

Authors:  Rachna Malani; Ankush Bhatia; Julia Wolfe; Christian Grommes
Journal:  Leuk Lymphoma       Date:  2019-01-10

Review 3.  New approaches in primary central nervous system lymphoma.

Authors:  Eleanor Fraser; Katherine Gruenberg; James L Rubenstein
Journal:  Chin Clin Oncol       Date:  2015-03

4.  Primary central nervous system lymphoma: is whole-body CT and FDG PET/CT for initial imaging reasonable?

Authors:  Hana Malikova
Journal:  Quant Imaging Med Surg       Date:  2019-09

Review 5.  Primary CNS lymphoma: findings outside the brain.

Authors:  U Herrlinger
Journal:  J Neurooncol       Date:  1999-07       Impact factor: 4.130

Review 6.  A systematic approach to the diagnosis of suspected central nervous system lymphoma.

Authors:  Brian J Scott; Vanja C Douglas; Tarik Tihan; James L Rubenstein; S Andrew Josephson
Journal:  JAMA Neurol       Date:  2013-03-01       Impact factor: 18.302

7.  How I treat CNS lymphomas.

Authors:  James L Rubenstein; Neel K Gupta; Gabriel N Mannis; Amanda K Lamarre; Patrick Treseler
Journal:  Blood       Date:  2013-08-20       Impact factor: 22.113

8.  Age-incidence patterns of primary CNS tumors in children, adolescents, and adults in England.

Authors:  Ramandeep S Arora; Robert D Alston; Tim O B Eden; Edward J Estlin; Anthony Moran; Jillian M Birch
Journal:  Neuro Oncol       Date:  2008-11-24       Impact factor: 12.300

9.  Diagnostic delay and prognosis in primary central nervous system lymphoma compared with glioblastoma multiforme.

Authors:  R Cerqua; S Balestrini; C Perozzi; V Cameriere; S Renzi; G Lagalla; G Mancini; M Montanari; P Leoni; M Scerrati; M Iacoangeli; M Silvestrini; S Luzzi; L Provinciali
Journal:  Neurol Sci       Date:  2015-08-02       Impact factor: 3.307

Review 10.  Progress in central nervous system lymphomas.

Authors:  Chia-Ching Wang; Julia Carnevale; James L Rubenstein
Journal:  Br J Haematol       Date:  2014-05-16       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.